Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CDCA3 |
| Upstream (Parents) |
|---|
| (<<) KIF20A → CDCA3 |
| (<<) ASPM → CDCA3 |
| (<<) FOXM1 → CDCA3 |
| (<<) RAD51AP1 → CDCA3 |
| Downstream (Children) |
|---|
| CDCA3 → FAM117B (>>) |
| CDCA3 → SPATA20 (>>) |
| CDCA3 → FANCD2 (>>) |
| CDCA3 → KIF15 (>>) |
| CDCA3 → HMGB2 (>>) |
| CDCA3 → KIF20A (>>) |
| CDCA3 → PRMT3 (>>) |
| CDCA3 → ASPM (>>) |
| CDCA3 → TCFL5 (>>) |
| CDCA3 → C5orf25 (>>) |
| CDCA3 → SLC46A3 (>>) |
| CDCA3 → CENPA (>>) |
| CDCA3 → CENPO (>>) |
| CDCA3 → NEIL3 (>>) |
| CDCA3 → CDT1 (>>) |
| CDCA3 → CST2 (>>) |
| CDCA3 → TSC22D3 (>>) |
| CDCA3 → CDCA7 (>>) |
| CDCA3 → FOXM1 (>>) |
| CDCA3 → NOL4 (>>) |
| CDCA3 → IL17RB (>>) |
| CDCA3 → CDC25A (>>) |
| CDCA3 → BICD1 (>>) |
| CDCA3 → DERA (>>) |
| CDCA3 → LOC100129361 (>>) |
| CDCA3 → GPR19 (>>) |
| CDCA3 → NPM1 (>>) |
| CDCA3 → ASB9 (>>) |
| CDCA3 → RAD51AP1 (>>) |
| CDCA3 → NCAPD2 (>>) |
| CDCA3 → NSD1 (>>) |
| CDCA3 → MCAM (>>) |
| CDCA3 → CSE1L (>>) |
| CDCA3 → MCM6 (>>) |
| CDCA3 → TTF2 (>>) |
| CDCA3 → TMEM201 (>>) |
| CDCA3 → FAM64A (>>) |
